A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

Current weight-loss and diabetes medications, such as GLP-1 drugs, often fail to deliver lasting results and are plagued by ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) without considering cardiovascular and kidney risks, according to a BMJ ...

Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly for allegedly bribing and ...

Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...

Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.

Chrissy Metz has opened up about her health journey, sharing her nuanced views on weight loss drugs such as Ozempic.

Keeping blood pressure below 120/80 lowers risk of dementia, as well as heart and kidney disease, new guidelines say.

An increasingly popular class of drugs is just one of the factors fueling the sticker shock. Two generations are making a risky bet on housing. It may not pay off. A class-action lawsuit is a warning ...